西藏药业：9月2日将召开2025年第一次临时股东大会

Core Viewpoint - Tibet Pharmaceutical (600211) announced that it will hold its first extraordinary general meeting of shareholders on September 2, 2025, to review multiple proposals, including the proposal to abolish the supervisory board [1] Group 1 - The extraordinary general meeting is scheduled for September 2, 2025 [1] - The agenda includes the proposal to cancel the supervisory board [1]